Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
The study began in December 2023 with estimated completion in May 2026 and is currently actively recruiting across multiple international sites, with Phase 1 healthy volunteer data showing favorable safety profile, dose-proportional pharmacokinetics with 2-week half-life, and approximately 50% reduction in PD-1 expressing CD4+ and CD8+ T cells lasting over 30 days, supporting progression to this Phase 2 efficacy trial (67)
Look at Other Choices : If our coverage aint cutting it, check out options like compounded versions
Wegovy is FDA approved for chronic weight management in adults and adolescents 12 years and older with obesity or adults with overweight and at least one weight-related medical condition
10.1055/s-0035-1569330 35 DarabianS.HormuzM.LatifM
Cost barriers She praised Medicares new GLP-1 Bridge Program, which lowers monthly costs for eligible beneficiaries to about $50 if their Part D plans do not already provide coverage
Eligibility is based on BMI and health criteria, not cosmetic goals
US$ 22.86
US$ 26.61
US$ 21.91
US$ 23.98
US$ 25.76
US$ 26.24
US$ 23.67
